Antimicrobial peptides CS-piscidin-induced cell death involves activation of RIPK1/PARP, and modification with myristic acid enhances its stability and tumor-targeting capability

[1]  O. Bakare,et al.  Biomedical Relevance of Novel Anticancer Peptides in the Sensitive Treatment of Cancer , 2021, Biomolecules.

[2]  M. Wangpaichitr,et al.  Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration , 2021, International journal of molecular sciences.

[3]  Lin Hu,et al.  Myristoylation-mediated phase separation of EZH2 compartmentalizes STAT3 to promote lung cancer growth. , 2021, Cancer letters.

[4]  Zhengshuang Xu,et al.  Improvement on Permeability of Cyclic Peptide/Peptidomimetic: Backbone N-Methylation as A Useful Tool , 2021, Marine drugs.

[5]  Haisheng Peng,et al.  Delivery of RGD-modified liposome as a targeted colorectal carcinoma therapy and its autophagy mechanism , 2021, Journal of drug targeting.

[6]  Shixia Bu,et al.  Efficient iron utilization compensates for loss of extracellular matrix of ovarian cancer spheroids. , 2021, Free radical biology & medicine.

[7]  Xiaowan Ma,et al.  Cerocin, a novel piscidin-like antimicrobial peptide from black seabass, Centropristis striata. , 2020, Fish & shellfish immunology.

[8]  L. Kuroki,et al.  Treatment of epithelial ovarian cancer , 2020, BMJ.

[9]  W. Zhou,et al.  Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation , 2020, Oncogene.

[10]  Shuaibing Shi,et al.  N-terminal Myristoylation Enhanced the Antimicrobial Activity of Antimicrobial Peptide PMAP-36PW , 2020, Frontiers in Cellular and Infection Microbiology.

[11]  N. Hacker,et al.  The untapped potential of ascites in ovarian cancer research and treatment , 2020, British Journal of Cancer.

[12]  T. Meinnel,et al.  Myristoylation, an Ancient Protein Modification Mirroring Eukaryogenesis and Evolution. , 2020, Trends in biochemical sciences.

[13]  W. El-Deiry,et al.  Targeting apoptosis in cancer therapy , 2020, Nature Reviews Clinical Oncology.

[14]  M. Akrami,et al.  Recent progress in biomedical applications of RGD-Based ligand: From precise cancer theranostics to biomaterial engineering: A systematic review. , 2019, Journal of biomedical materials research. Part A.

[15]  M. D'Arcy.  Cell death: a review of the major forms of apoptosis, necrosis and autophagy , 2019, Cell biology international.

[16]  Zhepeng Liu,et al.  RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability. , 2019, International journal of pharmaceutics.

[17]  Yuanhui Ji,et al.  RGD‐modified polymer and liposome nanovehicles: Recent research progress for drug delivery in cancer therapeutics , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[18]  A. Letai,et al.  Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins , 2019, Nature Reviews Molecular Cell Biology.

[19]  In-geun Ryoo,et al.  High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling , 2018, Cell Death & Disease.

[20]  D. Sharma,et al.  Necroptosis: a regulated inflammatory mode of cell death , 2018, Journal of Neuroinflammation.

[21]  D. Armstrong.  New Therapies for Ovarian Cancer. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[22]  R. Borojevic,et al.  Characterization of Gastrospheres Using 3D Coculture System. , 2018, Methods in molecular biology.

[23]  A. Toplak,et al.  Enzyme-catalyzed peptide cyclization. , 2017, Drug discovery today. Technologies.

[24]  D. Xing,et al.  RGD peptide-modified fluorescent gold nanoclusters as highly efficient tumor-targeted radiotherapy sensitizers. , 2017, Biomaterials.

[25]  P. Kroeger,et al.  Pathogenesis and heterogeneity of ovarian cancer , 2016, Current opinion in obstetrics & gynecology.

[26]  S. Narod,et al.  Can advanced-stage ovarian cancer be cured? , 2016, Nature Reviews Clinical Oncology.

[27]  A. Letai,et al.  Mitochondria-Judges and Executioners of Cell Death Sentences. , 2016, Molecular cell.

[28]  David John Adams,et al.  Cyclic-RGDfK peptide conjugated succinoyl-TPGS nanomicelles for targeted delivery of docetaxel to integrin receptor over-expressing angiogenic tumours. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[29]  Carmela Fimognari,et al.  Broad targeting of resistance to apoptosis in cancer , 2015, Seminars in cancer biology.

[30]  T. Mak,et al.  Caspase functions in cell death and disease. , 2015, Cold Spring Harbor perspectives in biology.

[31]  Qiang Z Yu,et al.  Apoptosis, autophagy, necroptosis, and cancer metastasis , 2015, Molecular Cancer.

[32]  Maria Markaki,et al.  Crosstalk between apoptosis, necrosis and autophagy. , 2013, Biochimica et biophysica acta.

[33]  David R McIlwain,et al.  Caspase functions in cell death and disease. , 2013, Cold Spring Harbor perspectives in biology.

[34]  V. Préat,et al.  RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. , 2012, Molecular pharmaceutics.

[35]  Fan Wang,et al.  Evaluation of 111In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability , 2011, Theranostics.

[36]  G. V. Chaitanya,et al.  PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration , 2010, Cell Communication and Signaling.

[37]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[38]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[39]  Horst Kessler,et al.  RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. , 2003, Biomaterials.